ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea · Delayed Price · Currency is KRW 2,545.00
+65.00 (2.62%)
At close: May 18, 2026
ADBiotech Market Cap
ADBiotech has a market cap or net worth of 50.08 billion as of May 19, 2026. Its market cap has increased by 154.42% in one year.
Market Cap
50.08B
Enterprise Value
55.47B
Revenue
12.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,545.00
Market Cap Chart
Since December 24, 2019, ADBiotech's market cap has increased from 25.35B to 50.08B, an increase of 97.61%. That is a compound annual growth rate of 11.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 50.08B | 50.80% |
| Dec 30, 2025 | 33.21B | 74.69% |
| Dec 30, 2024 | 19.01B | -36.49% |
| Dec 28, 2023 | 29.93B | -2.53% |
| Dec 29, 2022 | 30.71B | -31.89% |
| Dec 30, 2021 | 45.09B | 20.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shaperon | 66.91B |
| Quratis | 66.19B |
| Progen | 63.65B |
| EyeGene | 62.64B |
| HLB Pep | 61.34B |
| Psomagen | 59.73B |
| J2KBIO | 54.91B |
| Aptamer Sciences | 51.97B |